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Yan J. Jiang1, Biao Lu1, Peggy Kim1, Gyorgy Paragh2, Gerd Schmitz2, Peter M. Elias3 and
Kenneth R. Feingold1
ATP-binding cassette (ABC) transporter, family 12 (ABCA12), a member of the ABC superfamily, facilitates the
delivery of lipids to lamellar bodies (LB) in keratinocytes, which is critical for permeability barrier function.
Recently, gene mutations of ABCA12 were found to underlie Harlequin ichthyosis and lamellar ichthyosis, two
devastating skin disorders. Previously we and others have demonstrated that peroxisome proliferators-activated
receptors (PPARs) and liver X receptor (LXR) activation improved epidermal permeability barrier homeostasis by
stimulating keratinocyte differentiation, lipid synthesis, and increasing LB formation/secretion. Here we report
that both PPAR-g and -b/d activators markedly stimulate ABCA12 mRNA expression in cultured human
keratinocyte (CHK) in a dose- and time-dependent manner. Increased ABCA12 mRNA levels are accompanied by
an increase in ABCA12 protein, suggesting biological importance of this upregulation. LXR activators also
increase ABCA12 mRNA levels in CHK, but to a lesser extent. In contrast, activators of PPAR-a, RAR, RXR, or
vitamin D receptor did not alter ABCA12 expression. Two major ABCA12 alternative transcripts and their
corresponding proteins are also expressed and upregulated by PPAR or LXR activator in both undifferentiated
and differentiated CHK. Together, our data demonstrate that PPAR and LXR activators increase ABCA12
expression, providing an additional mechanism by which PPAR and LXR activators promote epidermal
permeability barrier homeostasis.
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INTRODUCTION
ATP-binding cassettes (ABC) are a large group of proteins that
mediate the transport of a variety of different substrates across
cellular membranes. These proteins contain two transmem-
brane domains and two ATP-binding domains or nucleotide-
binding folds. Forty-eight ABC genes have been identified to
date, which have been further divided into seven subfamilies,
based on sequence homology and organization of the
nucleotide-binding folds (Allikmets et al., 1996; Dean
et al., 2001; Borst and Elferink, 2002; Akiyama et al.,
2005). The ABCA subfamily comprises 12 full transporters
and one pseudogene (ABCA11), and all mediate lipid
transport (Schmitz et al., 2000). Most importantly, mutations
in ABCA proteins have been implicated in several autosomal
recessive disorders of lipid metabolism, including ABCA1 in
Tangier disease (Brooks-Wilson et al., 1999), ABCA4 in
Stargardt disease (Allikmets et al., 1997), and ABCA3 in fatal
surfactant deficiency in newborns (Shulenin et al., 2004).
ABCA12 is a member of the ABCA subfamily (Akiyama,
2006). The functional importance of ABCA12 was revealed
when a missense mutation was first reported to cause type 2
lamellar ichthyosis (Lefevre et al., 2003). Very recently,
severe mutations in ABCA12 were further identified to cause
Harlequin ichthyosis, a severe keratinizing disorder, which is
fatal in most affected newborns (Lefevre et al., 2003; Kelsell
et al., 2005). Evidence from morphological and biochemical
studies indicate that ABCA12 is important for lipid (gluco-
sylceramide) loading into lamellar body (LB) and its absence
results in a severe abnormality in permeability barrier
formation and extraordinary, intrauterine thickening of the
stratum corneum, ultimately resulting in high rates of prenatal
mortality (Akiyama et al., 2005). Strikingly, genetic correction
of ABCA12 deficiency in patients’ keratinocytes by gene
transfer normalized loading of glucosylceramides into LB
(Akiyama et al., 2005). Glucosylceramides are major
precursors of ceramides, which comprises 50% of the lipid
that forms the barrier (Uchida et al., 2000). Moreover, as
protein loading into LB is dependent on prior or concurrent
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lipid loading (Rassner et al., 1999), the failure to deliver lipids
may result in a deficiency in proteases, accounting in part for
the severe keratinizing disorder. Together, these studies
strongly indicate a critical role for ABCA12 in epidermal
physiology, specifically, the formation of LB and permeability
barrier homeostasis. Hence, understanding how this protein
is regulated could be great importance. Currently, however,
the factors that regulate ABCA12 expression in keratinocytes
remain unknown, although ABCA12 expression in cultured
human keratinocyte (CHK) increases with keratinocyte
differentiation (Akiyama et al., 2005).
Previously, we and others have demonstrated that peroxi-
some proliferators-activated receptor (PPAR)-a, -b/d, -g, as
well as liver X receptor (LXR)-a and -b, are expressed in
murine epidermis and human keratinocytes (Hanley et al.,
2000a, b; Westergaard et al., 2001; Komuves et al., 2002).
Activation of PPARs and LXRs have numerous differentiation-
related effects on keratinocytes, including (1) stimulating
corneocyte envelope precursor expression (Hanley et al.,
1998, 1999, 2000b); (2) increasing the expression of
Sult2B1b, which catalyzes the synthesis of cholesterol sulfate
(Jiang et al., 2005); (3) stimulating epidermal lipid synthesis
(Man et al., 2006); (4) acceleration of LB secretion (Man
et al., 2006); and (5) improving epidermal permeability
barrier homeostasis (Hanley et al., 1998, 1999, 2000a, b;
Komuves et al., 2000, 2002; Jiang et al., 2005; Man et al.,
2006). Very recently, we demonstrated that ABCA1, a
member of ABCA family that transports cholesterol and
phospholipids out of cells (Schmitz and Langmann, 2005), is
not only expressed in CHK and murine epidermis, but also
markedly stimulated by LXR, PPAR-a, PPAR-b/d activation
(Jiang et al., 2006). Based on these findings, we hypothesized
that activation of PPARs and LXR may also stimulate ABCA12
expression in keratinocytes.
RESULTS AND DISCUSSION
Initially, we examined the effect of the activation of LXR,
PPARs, RAR, RXR, and vitamin D receptor (VDR) on ABCA12
mRNA levels. The optimized dose for each activator was
determined, as described previously (Jiang et al., 2005). As
shown in Figure 1a, ABCA12 mRNA levels increased
markedly following treatment with PPAR-g activators (cigli-
tazone (Cig): 11.8-fold; troglitazone: 12-fold; GI 251929X:
6.4-fold) and PPAR-b/d activator (GW610742 (GW): 5.1-
fold), after 24 hours incubation. Furthermore, the upregula-
tion of ABCA12 by PPAR-g (Cig) occurred rapidly, was
sustained over an extend period of time (Figure 2a), and
occurred in a dose-dependent manner (Figure 2b). Similar
time- and dose-dependent upregulation of ABCA12 mRNA
was induced by PPAR-b/d (GW) activation (Figure S1). In
addition, although LXR activators modestly increased
ABCA12 mRNA level (TO901317 (TO): 3.3-fold), activators
of PPAR-a, RAR, RXR, or vitamin D receptor had no effect
(Figure 1a). As previous studies showed that keratinocyte
differentiation induced by calcium stimulate ABCA12 mRNA
expression after 4 days incubation (Akiyama et al., 2005), we
next assessed whether PPAR and LXR activators would further
increase ABCA12 mRNA levels in differentiated CHK,
induced by high calcium (1.2 mM). As shown in Figure 1b,
although high calcium itself did not induce significant
amount of ABCA12 mRNA, ligand activation of either
PPAR-g or -b/d increased ABCA12 mRNA levels by 11- and
4.5-fold, respectively, even in high calcium. Similarly, LXR
activation by TO increased ABCA12 mRNA level by 2.3-fold
(Po0.01). Consistent with the observations in undifferen-
tiated CHK (above), PPAR-a activation had no effect on
ABCA12 mRNA (Figure 1b). Furthermore, ligand treatment
(5 mm Cig or 8 mm GW) of CHK for 4 days in high calcium
medium increased, ABCA12 mRNA 2.2- and 1.8-fold,
respectively, compared with high calcium alone (data not
shown). Thus, under our experimental condition, certain
PPAR and LXR activators stimulate ABCA12 mRNA expres-
sion, independent of keratinocyte differentiation.
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Figure 1. Activation of PPAR-c, PPAR-b/d, and LXR increase ABCA12 mRNA
expression in CHK. (a) Cells were incubated with either vehicle control, or
activators of LXR (10 mM 22R or 10 mM TO); PPAR-g (7.5 mM Cig, or 7.5 mM
troglitazone (Tro), or 10mM GI); PPAR-b/d GW (8mM); PPARa (20mM WY14643
or 400 mM CLO); RAR (1 mM all-trans retinoic acid); RXR (1 mM 9-cis-retinoic
acid); vitamin D receptor (1a, 25-dihydroxyvitamin D3 0.1mM) in low calcium
medium for 24 hours (h). (b) Alternatively, cells were incubated in either
0.03 mM Ca2þ medium, or 1.2 mM Ca2þ medium alone, or 1.2 mM Ca2þ
medium with 10 mM TO, or 5 mM Cig, or 8 mM GW, or 20mM WY14643 for
24 hours. Real-time PCR was performed to measure mRNA levels of ABCA12
and cyclophilin (internal control), as described in ‘‘Materials and Methods’’.
Data are expressed as percentage of control (100%) and presented as
mean7SEM (n¼ 3 in each group). Similar results were obtained when the
experiment was repeated with a different batch of cells. **Po0.01;
***Po0.001.
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Previously, we reported that three alternate variants of
ABCA1 are expressed in CHK, which contribute equally to
the increase in ABCA1 mRNA in response to LXR activation
(Jiang et al., 2006). As in the case of ABCA1 (Singaraja et al.,
2001, 2005), two major splicing transcripts of ABCA12 have
recently been described (Lefevre et al., 2003), which were
assigned as hABCA12-L and hABCA12-S in this study (Figure
3a). ABCA12-L (NM_173076) gene consists of 53 exons with
a coding sequence of 9112 bp, which is translated into a
protein of 2595 amino acids with a calculated molecular
weight of 293.4 kDa. ABCA12-S (NM_015657) gene consists
of 8097 bp, with 45 exons coding for a protein of 2277 amino
acids with a calculated molecular weight of 257 kDa (Figure
3a). To determine which of these transcripts are expressed in
CHK, we designed specific primer pairs (Table 1) for both
hABCA12-L and -S, and used quantitative real-time PCR to
measure their mRNA levels. As shown in Figure 3b, both
transcripts are expressed at moderate levels in Ca2þ -
differentiated CHK; following 24 hours incubation, PPARg
activator Cig increased both transcripts by 4.4- and 5.8-fold,
respectively. Similarly, PPAR-b/d (GW) or LXR activator
(22(R)-OH-cholesterol) increased both transcripts by 2- and
2.5-fold, respectively (Figure 3b). Again, activation of PPAR-a
had no effect on either transcript (Figure 3b). When
undifferentiated keratinocytes were used, similar results were
obtained (data not shown).
Most importantly, polyclonal antibodies against human
ABCA12 recognized both 293.3 kDa (upper) and 257 kDa
(lower bands) under basal condition, corresponding to gene
products of ABCA12-L and -S, respectively (Figure 4a). As
expected, activation of PPAR-g by Cig increased ABCA12
protein expression (upper and lower band, 220 and 317%,
respectively) in differentiated CHK (Figure 4). Furthermore,
activation of PPAR-b/d by GW also caused a 175–182%
increase in ABCA12 protein in these cells (Figure S2). Finally,
both Cig and GW also stimulated ABCA12 protein in
undifferentiated CHK (data not shown). Thus, PPAR-g and
-b/d activators upregulate both transcripts of ABCA12 and
their corresponding isoforms. The function of these isoforms,
however, remains unknown.
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Figure 2. Activation of PPAR-c increases ABCA12 mRNA level in a time- and
dose-dependent manner. (a) Cells were incubated with 5 mM Cig for various
periods of time (0, 6, 16, 24, and 48 h) in 0.03 mM Ca2þ medium.
(b) Alternatively, cells were incubated with Cig at various concentrations (0,
2.5, 5.0, 7.5, 10 mM) in the same medium for 24 hours. ABCA12 and
cyclophilin mRNA levels were measured as described. Data are expressed as
percentage of vehicle control (100%) and presented as mean7SEM (n¼ 3 in
each group). Similar results were obtained when the experiment was repeated
with a different batch of cells. *Po0.05; **Po0.01; ***Po0.001.
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Figure 3. Alternate transcripts of ABCA12 are expressed in CHK and
upregulated by PPAR-c, PPAR-b/d, and LXR activators. (a) Genomic structure
of human ABCA12 locus and ABCA12 isoforms. Two major hABCA12
cDNAs, ABCA12-L and -S, are transcribed by alternative usage of two
transcription initiation start sites, TISS1 and TISS2. Exon 1–8 are found only in
ABCA12-L transcript. Two major human ABCA12 protein isoforms are
synthesized accordingly. ABCA12-L and -S proteins share a large common
C-terminus, however, with a unique 328 amino acids (aa) or 10 aa at
N-terminus, respectively. (b) Cells were incubated in either 0.03 mM or
1.2 mM Ca2þ medium alone, or 1.2 mM Ca2þ medium with 10mM TO, or
5mM Cig, or 8mM GW, or 20mM WY14643 for 24 hours. Human ABCA12-L,
-S, and cyclophilin mRNA levels were determined by real-time PCR. Under
our experimental conditions, the absolute Ct values (mean from triplicates) for
the basal levels of these two transcripts, hABCA12-L and -S are 25.4 and 30.9,
respectively. Data are expressed as percentage of control (100%) and
presented as mean7SEM (n¼ 6 in each group). **Po0.01; ***Po0.001.
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The epidermal permeability barrier, which is a prerequisite
for terrestrial life, resides in the outermost layers of the
mammalian epidermis and is comprised of lamellar mem-
branes enriched in non-polar lipids that are derived from the
secretion of LB by stratum granulosum cells (Elias and
Menon, 1991). Abnormal LB formation or secretion leads to
the failure of the formation of a functional barrier; a severe
case occurs in the disease Harlequin ichthyosis. Ultra-
structurally, in cultured Harlequin ichthyosis keratinocytes,
ABCA12 deficiency leads to an abnormality in the formation
and secretion of LBs, which is associated with alterations in
the distribution pattern of glucosylceramide (Akiyama et al.,
2005). It is hypothesized that ABCA12 mediates the transport
of sphingolipids (i.e., glucosylceramide) into LB, which is
critical for a competent barrier formation.
Previously, we have shown that activation of LXR, PPARa,
PPARb/d, and PPARg improves permeability barrier home-
ostasis (Hanley et al., 1999, 2000a, b; Komuves et al., 2000,
2002). This could be attributed to their effects on both the
protein (corneocytes) ‘‘brick’’ and the lipid ‘‘mortar’’
components of the stratum corneum. Corneocytes provide a
scaffold for the organization of the lipid matrix into highly
organized lammelar membranes. Activation of PPARs and
LXR has been shown to stimulate keratinocyte differentiation
and the formation of the cornified envelope (Hanley et al.,
1998, 1999, 2000a, b; Komuves et al., 1999; Westergaard
et al., 2001; Mao-Qiang et al., 2004; Schmuth et al., 2004).
Activation of PPARs and LXR has also been shown to
stimulate LB secretion, epidermal lipid synthesis, and lipid
processing in the stratum corneum (Man et al., 2006), as well
as stimulate SULT2B1b expression, the key enzyme in the
synthesis of cholesterol sulfate (Jiang et al., 2005). Together,
these effects on both the bricks and mortar portions of the
stratum corneum could account for the improvement in
permeability barrier homeostasis induced by PPAR and LXR
activator treatment. In this study, we further demonstrate that
PPAR and LXR activators increase ABCA12 expression, which
could facilitate lipid movement and LB formation, thereby
providing another mechanism by which PPAR and LXR
activators promote epidermal permeability barrier home-
ostasis.
MATERIALS AND METHODS
Materials
22(R)-OH-cholesterol, clofibric acid (CLO), WY14643, all-trans-
retinoic acid, and 9-cis-retinoic acid were purchased from Sigma
(St Louis, MO). Cig, troglitazone, and TO were purchased from
Cayman Chemical Co. (Ann Arbor, MI). Synthetic PPAR-d activator
Table 1. The human primer sequence for real-time PCR
Gene Primer sequence Amplicon (bp) A Accession no.
ABCA12 (F) 50-ACAGGAATGGCCTTCATCAC-30 317 AY033486
(R) 50-AACATGGTGCCCTGAGAAAC-30
ABCA12-L (F) 50-TGCAACTAACGAAGGTTTCAGA-30 116 NM_173076
(R) 50-CATCCTCATTCCACACATGC-30
ABCA12-S (F) 50-ACCTGGGATGGTTTTCACTG-30 144 NM_015657
(R) 50-TGCTTGGAGATAAGGTCTGTCC-30
Cyclophilin (F) 50-TCTCCTTTGAGCTGTTTGCAG-30 326 Y00052
(R) 50-CACCACATGCTTGCCATC-30
ABCA12, ATP-binding cassette transporter, family 12.
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Figure 4. PPAR-c activation increases ABCA1 protein expression. (a) Cells
were incubated with vehicle or 5mM Cig in 1.2 mM Ca2þ medium for
48 hours. The whole cell extract was prepared and subjected to Western blot
analyses to determine ABCA12 protein as described. A representative blot is
shown. (b) The densitometry values from a typical Western blot are expressed
as percentage of control (100%), plotted, and presented as mean values (n¼ 2
in each group). Similar results were obtained when the experiment was
repeated with a different batch of cells.
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GW and PPAR-g activator GI 251929X were generous gifts from Dr
Tim Willson (GlaxoSmithKline). 1a, 25-Dihydroxyvitamin D3 was
purchased from BIOMOL International (Plymouth Meeting, PA).
Molecular grade chemicals such as TRI Reagent were obtained from
either Sigma or Fisher Scientific (Fairlawn, NJ). The iScriptTMcDNA
Synthesis Kit for first-strand cDNA synthesis was purchased from
BIO-RAD Laboratories (Hercules, CA). All reagents and supplies for
Real-time PCR were purchased from Applied Biosystems (Foster
City, CA). Primary polyclonal antibody against human ABCA12 was
obtained from the University of Regensburg, Germany. All other
reagents for Western blot, including NuPAGEs Novex Pre-cast
gradient gels (3–8% Tris-Acetate), buffers, protein standards, and
detection kits, were purchased from Invitrogen (Carlsbadm, CA).
Keratinocyte culture
The second passage of human foreskin keratinocytes were seeded
and maintained as described (Jiang et al., 2006). In a typical
experiment, cells were treated with reagent at optimized concentra-
tion at pre-confluence (60–70%) in either low or high calcium
conditions for 24 hours, and were harvested at 80–100% confluence.
Alternatively, cells were incubated in the presence or absence of
ligands for 4 days in high calcium medium. Control keratinocytes
were treated with vehicle (0.05% ethanol or DMSO).
Real-time PCR
Real-time PCR was carried out as described previously (Jiang et al.,
2006). Briefly, following RNA isolation, cDNA was synthesized to
measure the relative mRNA levels of hABCA12 (full length),
alternative transcripts (hABCA12-L and -S). The primer sequences
for PCR are listed in Table 1. A mixture of (20 ml) individual PCR
reaction contains 30 ng cDNA, 450–600 nM forward or reverse
primers and 10 ml of 2 SYBR Green quantitative PCR Master Mix
(BIO-RAD). The PCR reaction was performed at 501C for 2 minutes,
951C for 10 minutes, and then 40 cycles of amplification of melting
at 951C for 30 seconds, annealing at 601C for 30 seconds, and
extension at 721C for 45 seconds, respectively. The PCR reaction was
performed in duplicate, with 3–4 samples in each group (n¼ 3–4).
Experiments were repeated at least once using a different batch of
cells to ensure reproducibility. Gel electrophoresis and melting
curve analyses were performed to confirm accurate PCR product
sizes and absence of nonspecific bands. The expression levels of
each gene were normalized against cyclophilin (an invariant
transcript) using the comparative Ct method, and expressed as
percentage of control, with the control as 100%.
Western blot analysis
Western blots were carried out according to the manufacturer’s
protocol. Briefly, the whole cell extract was prepared from CHK and
80–100 mg proteins were fractionated on pre-cast gels (3–8%) and
transferred to polyvinylidine difluoride membranes, overnight at
41C. The proteins on the membrane were subsequently probed with
polyclonal primary antibodies against human ABCA12 (1:1000), and
then visualized by horseradish peroxidase-conjugated anti-rabbit
secondary antibody (1:7500) using the Enhanced Chemilumines-
cence (ECL) Western Blotting Detection System Kit. Membranes
were then exposed to CL-XPosure film. An identical blot was probed
with anti-GAPDH antibody to verify the equal loading of protein
(data not shown).
Statistical analysis
All data are expressed as mean7SEM. Comparison between two
groups is undertaken using two-tail and unpaired t-test. Differences
in values are considered significant if Po0.05.
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SUPPLEMENTARY MATERIAL
Figure S1. Activation of PPAR-b/d increases ABCA12 mRNA levels in a
time- and dose-dependent manner.
Figure S2. PPAR-b/d activation also increases ABCA1 protein expression.
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